High fasting blood sugar caused approximately 133,000 pancreatic cancer deaths globally in 2021, accounting for 41% of all pancreatic cancer deaths that year. According to Gram Research analysis of global health data spanning 31 years, pancreatic cancer deaths linked to high blood sugar have increased 234% since 1990, with the highest rates in wealthier countries and East Asia. This dramatic rise underscores the critical importance of blood sugar management for cancer prevention.
A major global study tracking health data from 204 countries found that high fasting blood sugar levels are responsible for about 40% of pancreatic cancer deaths worldwide. Researchers discovered that pancreatic cancer cases linked to high blood sugar have more than tripled since 1990, with the biggest increases in East Asia and wealthier countries. The study shows that men and older adults are hit hardest by this trend. According to Gram Research analysis, controlling blood sugar through diet and lifestyle changes could significantly reduce the risk of developing this serious cancer.
Key Statistics
A 2026 longitudinal analysis of 204 countries found that high fasting blood sugar caused 132,753 pancreatic cancer deaths in 2021, representing 41% of all pancreatic cancer deaths globally.
According to research reviewed by Gram covering 31 years of global health data, pancreatic cancer deaths attributable to high blood sugar increased by 234% between 1990 and 2021.
A comprehensive 2026 study analyzing global disease burden data found that high blood sugar caused 2.75 million years of lost health and productivity from pancreatic cancer in 2021 alone.
Research shows that men and older adults experience disproportionately higher rates of pancreatic cancer linked to high blood sugar, with the largest absolute burden occurring in East Asia.
The Quick Take
- What they studied: How much pancreatic cancer around the world is caused by high fasting blood sugar levels, and how this has changed from 1990 to 2021.
- Who participated: Researchers analyzed health data from 204 countries and territories, looking at death records and disease statistics spanning 31 years.
- Key finding: In 2021, high blood sugar caused about 133,000 deaths from pancreatic cancer globally—accounting for 41% of all pancreatic cancer deaths that year. This represents a 234% increase since 1990.
- What it means for you: If you have high blood sugar or prediabetes, managing your glucose levels through diet, exercise, and medical care becomes even more important. This research suggests that better blood sugar control could prevent many pancreatic cancer cases, especially in regions with rising rates.
The Research Details
This was a longitudinal observational study, meaning researchers tracked health data over time without conducting experiments on people. They used information from the Global Burden of Disease 2021 study, which collects health statistics from every country in the world. The researchers looked at three decades of data (1990-2021) to see how pancreatic cancer cases linked to high blood sugar have changed over time.
They examined several important measurements: the number of deaths, the number of years people lost to disability or early death (called DALYs), and age-adjusted rates that account for differences in population age. They also broke down the data by sex, age groups, countries, and economic development levels to see which populations were most affected.
The researchers used statistical methods to calculate how quickly the problem was growing or shrinking in different regions. This approach allowed them to identify trends and compare pancreatic cancer burden across the entire world.
This type of study is important because it shows real-world patterns in disease and death across entire populations, rather than just in controlled laboratory settings. By tracking data over 31 years and across 204 countries, the researchers could identify which regions and groups are most affected and whether the problem is getting better or worse. This information helps governments and health organizations decide where to focus prevention efforts.
The study used data from the Global Burden of Disease project, which is one of the most comprehensive and respected sources of health statistics worldwide. The researchers provided uncertainty intervals around their numbers, showing they were transparent about the limits of their estimates. However, the study relied on existing data rather than new experiments, so the quality depends on how accurately countries reported their health information. Some countries have better health tracking systems than others, which could affect the accuracy of results.
What the Results Show
In 2021, high fasting blood sugar caused an estimated 132,753 deaths from pancreatic cancer worldwide. This accounted for about 41% of all pancreatic cancer deaths that year—meaning that roughly 2 out of every 5 pancreatic cancer deaths were linked to high blood sugar. The disease also caused 2.75 million years of lost health and productivity (measured as DALYs).
The most striking finding was how much the problem has grown. From 1990 to 2021, the number of pancreatic cancer deaths caused by high blood sugar increased by 234%—more than tripling in just three decades. The number of years lost to disability increased by 210% over the same period. This dramatic rise suggests that high blood sugar is becoming an increasingly serious risk factor for pancreatic cancer globally.
The burden was not evenly distributed around the world. Wealthier countries with higher development levels had the highest death rates from this cause. East Asia reported the largest total number of deaths and disability years, reflecting both the region’s large population and rising rates of high blood sugar. Men experienced significantly higher rates than women, and older adults were affected much more than younger people.
The study found important differences between regions. High-income countries showed the highest age-adjusted death rates, suggesting that wealthier nations are experiencing more pancreatic cancer cases linked to high blood sugar. However, East Asia had the largest absolute number of cases, indicating that the sheer size of populations in that region means more people are affected overall. The researchers also noted that the rate of increase (how fast the problem is growing) was inversely related to how developed a country was—meaning less wealthy regions are seeing faster growth in these cases, suggesting the problem may spread as countries develop.
This research confirms what other studies have suggested: high blood sugar is a major risk factor for pancreatic cancer. However, this study provides the most comprehensive global picture to date, covering more countries and a longer time period than previous analyses. It shows that the problem is not stable—it’s growing rapidly, which is a new and concerning finding. The study also highlights that this is the second-most important metabolic risk factor for pancreatic cancer globally, after obesity, emphasizing the importance of glucose control.
The study relied on health data reported by countries, and some nations have better health tracking systems than others. This means estimates for some countries may be less accurate than others. The researchers couldn’t determine cause and effect—they showed that high blood sugar and pancreatic cancer are linked, but couldn’t prove that high blood sugar directly causes cancer in every case. Additionally, the study couldn’t account for all factors that might influence pancreatic cancer risk, such as smoking or family history. Finally, because this is observational data, we can’t be certain about the exact mechanisms explaining why high blood sugar increases cancer risk.
The Bottom Line
People with high blood sugar, prediabetes, or diabetes should work with their healthcare providers to manage their glucose levels through diet, exercise, and medication if needed. This research provides strong evidence that controlling blood sugar is important not just for preventing diabetes complications, but also for reducing pancreatic cancer risk. Public health efforts should focus on preventing high blood sugar through nutrition education and lifestyle programs, particularly in regions experiencing rapid increases in these cases. Confidence level: High—this finding is based on comprehensive global data and aligns with existing research on blood sugar and cancer risk.
Anyone with high blood sugar, prediabetes, or type 2 diabetes should pay attention to this research. People in East Asia and high-income countries should be particularly aware, as these regions show the highest burden. Men and people over 50 should take special note, as they face higher risk. Healthcare providers, public health officials, and policymakers should use this information to prioritize glucose control programs. People without blood sugar problems can use this as motivation to maintain healthy eating habits and exercise to prevent high blood sugar from developing.
Improvements in blood sugar control can reduce inflammation and other cancer-related processes relatively quickly—within weeks to months of better glucose management. However, cancer prevention is a long-term process. It typically takes years of sustained good blood sugar control to meaningfully reduce pancreatic cancer risk. People should view this as a long-term health investment rather than expecting immediate results.
Frequently Asked Questions
Does high blood sugar actually cause pancreatic cancer?
High blood sugar is strongly linked to pancreatic cancer risk and accounts for 41% of pancreatic cancer deaths globally. While this research shows the connection, it doesn’t prove that high blood sugar directly causes cancer in every case. Other factors like genetics, smoking, and obesity also play roles. Managing blood sugar remains important for cancer prevention.
How much has pancreatic cancer from high blood sugar increased worldwide?
Pancreatic cancer deaths linked to high blood sugar have increased 234% since 1990—more than tripling in three decades. This represents one of the fastest-growing cancer risk factors globally, with particularly steep increases in less wealthy regions experiencing rapid development.
Which countries are most affected by pancreatic cancer from high blood sugar?
East Asia has the largest total number of cases due to its large population. However, wealthier, high-income countries show the highest death rates per person. The problem is growing fastest in middle-income countries experiencing economic development and lifestyle changes.
What can I do to reduce my pancreatic cancer risk from high blood sugar?
Control your blood sugar through diet (limit refined carbohydrates and sugar), regular exercise (especially after meals), maintain a healthy weight, and work with your doctor if you have prediabetes or diabetes. These lifestyle changes reduce blood sugar levels and inflammation, both linked to lower cancer risk.
Why are men more affected by pancreatic cancer from high blood sugar?
The study found men experience significantly higher rates than women, though the exact reasons aren’t fully clear. Possible factors include differences in how men and women develop high blood sugar, lifestyle factors, and biological differences in cancer risk. More research is needed to understand these sex differences.
Want to Apply This Research?
- Track fasting blood glucose readings weekly (if you have a glucose monitor) or track blood sugar-related behaviors daily: number of servings of refined carbohydrates consumed, minutes of exercise completed, and glasses of water drunk. Set a goal to reduce refined carbohydrate servings by 2-3 per week.
- Use the app to log meals and identify which foods spike your blood sugar the most. Replace one high-sugar snack or drink per day with a protein-rich or fiber-rich alternative. Set reminders for 30-minute walks after meals, which research shows helps control blood sugar spikes.
- Check your fasting blood glucose monthly if possible (through your doctor), or track the proxy behaviors mentioned above weekly. Monitor trends over 3-month periods rather than day-to-day fluctuations. Share your app data with your healthcare provider to adjust diet and exercise plans as needed.
This research shows a strong association between high fasting blood sugar and pancreatic cancer, but does not prove that high blood sugar directly causes pancreatic cancer in all cases. This information is for educational purposes and should not replace professional medical advice. If you have concerns about your blood sugar levels or pancreatic cancer risk, consult with your healthcare provider. People with diabetes or prediabetes should work with their medical team on appropriate management strategies. This study analyzed population-level data and may not apply equally to all individuals.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.